Stephen Curtis
InvestorManaging Partner at MPM BioImpact
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
Experience
- BrightEdge - American Cancer SocietyInterim VP, Innovation & Impact Investing and Managing Directorcurrent2022 — present
- NextPoint Therapeutics, Inc.Strategy / Business Development Consultantcurrent2022 — present
- NextPoint Therapeutics, Inc.Interim COO / Board of Directors2019 — 2022Cambridge, Massachusetts, United States
- Kauffman FellowsCo-Chair - Boston Chapter2015 — 2022
- Kauffman FellowsCo-Chair - Healthcare SIG2015 — 2022
- Kauffman FellowsFellow - Class 202015 — 2017
- MPM CapitalStealth NewCos - Founding Board Member and COO/CBO2018 — 2022Cambridge, Massachusetts, United States
- MPM CapitalManaging Director - Oncology Innovations2018 — 2022Greater Boston Area
- MPM CapitalPrincipal2018Greater Boston Area
- Dyne TherapeuticsBoard Observer2018 — 2020Cambridge, Massachusetts, United States
- Eli Lilly and CompanySr Director, Business Development - Emerging Technology and Innovation2017 — 2018Greater Boston Area
- 2M Companies, Inc.Bioscience Ventures2014 — 2016Dallas/Fort Worth Area
- Reata Pharmaceuticals, Inc.Licensing & Intellectual Property | Biopharmaceutical Leadership Development Program2011 — 2014Irving, TX
- Siemens Venture CapitalMarket Analyst Intern2010 — 2011Boston, MA
- Laboratory of Dr. Carla Kim, Harvard Medical SchoolDoctoral Student2006 — 2011Boston, MA
- Forest Laboratories (now Allergan)Research Assistant2006Commack, NY
- Laboratory of Dr. Alexander Nikitin, Cornell UniversityHonors Research Student2002 — 2006Ithaca, NY
- The Collaborative Group (now a subdivision of BASF)Research Intern2003Stonybrook, NY
Education
- Harvard Medical SchoolDoctor of Philosophy (Ph.D.), Biological and Biomedical Sciences2006 — 2011
- Cornell UniversityBachelor of Science (B.S.), Molecular and Cellular Biology; Applied Economics and Management2001 — 2006
Skills & more
Venture CapitalLife SciencesStart-upsBiotechnologyEntrepreneurshipBusiness DevelopmentBusiness StrategyBiopharmaceuticalsDrug DiscoveryDrug DevelopmentCancerOncology
+3 more
Molecular BiologyImpact InvestingVenture PhilanthropyFrom Stephen's professional profile.
Colleagues at MPM BioImpact
Alim Ladha
Senior Associate at MPM Capital
Andrew Scharenberg
Entrepreneur Partner at MPM BioImpact
Ansbert Gadicke, M.D.
Chairman at MPM BioImpact
Ansbert K. Gadicke
Managing Partner at MPM BioImpact
Aparna Parikh
Entrepreneur Partner at MPM BioImpact
Bard Geesaman
Managing Partner at MPM Capital
Binsen Li
Principal at MPM BioImpact
Brendan Furey
Chief Compliance Officer at MPM BioImpact
Frequently asked questions
- Where does Stephen Curtis work?
- Stephen Curtis is Managing Partner at MPM BioImpact.
- What check size does Stephen Curtis write?
- Stephen Curtis typically writes checks of $100K – $5M.
Same school
Also attended Harvard Medical School135
Niko BonatsosInvestment Team at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
+ 129 more
Also attended Cornell University703
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerJenny LeeSenior Managing Partner at Granite AsiaNeeraj AgrawalGeneral Partner at Battery VenturesMichelle FernandesInvestor at Index VenturesMicah RosenbloomGeneral Partner at Founder CollectiveAlexandra FarmerPrincipal at Intel Capital, North America
+ 697 more
Shared employers
Also worked at Kauffman Fellows366
Jenny LeeSenior Managing Partner at Granite AsiaTobi CokerDeal Partner at Felicis VenturesRoi Bar-KatManaging Director at Intel CapitalAvi BharadwajInvestment Director at Intel CapitalNick WashburnSenior Managing Director, Intel Capital (North America)Vinnie LauriaFounding Partner at Golden Gate Ventures
+ 360 more
Also worked at Dyne Therapeutics5
Also worked at Eli Lilly and Company79
David MollerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock VenturesRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesCarlos PayaVenture Partner at Ysios CapitalKjersti FrognerInvestor at Almi Invest
+ 73 more

















.png)























